PMED there will be stock and emotional highs and lows as this company moves its operations forward.
* there will be execution and experiential successes and things that don't go as planned and thus learning opportunities.
* BUT, for me, I believe in Dr. Kushwah, his technology, his unique thinking, and ultimately in the business and equity success of his company.....PMED.
* I have no doubt that you will see revenue from the health-care space and revenue from the non health-care business space by the end of May. I honestly think we could see both within the next two to three weeks.
* I believe we will be revenue positive by the end of Q2 on the health-care revenue algo alone! Then the big revenue will come with Hindalco in Q3 sometime. I, personally, expect $10 to $20 mm USD from Hindalco alone! I also recall Hindalco cut the clinical study off at a half-way point to enter the actual commercial clinical trial deployment phase. Today....PMED technology is deployed and screening in an $800 mm USD HIndalco coal fired power plant and aluminum production facility in India! Their impairment technology is in the field...now!
The medical deployment will occur, with revenue, from multiple streams within weeks! Period!